TY - JOUR
T1 - Cooperative action of cellular proteins YB-1 and Purα with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element
AU - Chen, Nancie N.
AU - Chang, Chun Fan
AU - Gallia, Gary L.
AU - Kerr, Douglas A.
AU - Johnson, Edward M.
AU - Krachmarov, Chavdar P.
AU - Barr, Sharon M.
AU - Frisque, Richard J.
AU - Bollag, Brigitte
AU - Khalili, Kamel
PY - 1995/2/14
Y1 - 1995/2/14
N2 - Human JC polyomavirus (JCV) is the etiologic agent of the neurodegenerative disease progressive multifocal leukoencephalopathy. By using JCV as a model, we investigated the role of the viral early protein tumor antigen (TAg) in the binding of two cellular proteins, Purα and YB-1, to JCV regulatory sequences. Results from band-shift assays with purified YB- 1, Purα, and TAg indicated that efficient binding of Purα, a strong activator of early gene transcription, to a single-stranded target sequence corresponding to the viral lyric control element, is diminished in the presence of the late gene activator YB-1, which recognizes the opposite strand of the Purα binding site. Of particular interest was the ability of Purα and TAg to enhance binding of YB-1 to DNA molecules without being associated with this complex. Binding studies using a mutant peptide encompassing the N terminus of YB-1 indicated that the C terminus of YB-1 is important for its DNA binding activity. The ability of Purα and TAg to increase binding of YB-1 to DNA is independent of the YB-1 C terminus. Similarly, results from band-shift assays using Purα variants indicated that two distinct regions of this protein contribute either to its ability to bind DNA or to its ability to enhance YB-1 DNA binding activity. Based on the interaction of Purα, YB-1, and TAg, and their binding to DNA, a model is proposed for the role of these proteins in transcription of viral early and late genes during the lyric cycle.
AB - Human JC polyomavirus (JCV) is the etiologic agent of the neurodegenerative disease progressive multifocal leukoencephalopathy. By using JCV as a model, we investigated the role of the viral early protein tumor antigen (TAg) in the binding of two cellular proteins, Purα and YB-1, to JCV regulatory sequences. Results from band-shift assays with purified YB- 1, Purα, and TAg indicated that efficient binding of Purα, a strong activator of early gene transcription, to a single-stranded target sequence corresponding to the viral lyric control element, is diminished in the presence of the late gene activator YB-1, which recognizes the opposite strand of the Purα binding site. Of particular interest was the ability of Purα and TAg to enhance binding of YB-1 to DNA molecules without being associated with this complex. Binding studies using a mutant peptide encompassing the N terminus of YB-1 indicated that the C terminus of YB-1 is important for its DNA binding activity. The ability of Purα and TAg to increase binding of YB-1 to DNA is independent of the YB-1 C terminus. Similarly, results from band-shift assays using Purα variants indicated that two distinct regions of this protein contribute either to its ability to bind DNA or to its ability to enhance YB-1 DNA binding activity. Based on the interaction of Purα, YB-1, and TAg, and their binding to DNA, a model is proposed for the role of these proteins in transcription of viral early and late genes during the lyric cycle.
UR - http://www.scopus.com/inward/record.url?scp=0028799664&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028799664&partnerID=8YFLogxK
U2 - 10.1073/pnas.92.4.1087
DO - 10.1073/pnas.92.4.1087
M3 - Article
C2 - 7862639
AN - SCOPUS:0028799664
SN - 0027-8424
VL - 92
SP - 1087
EP - 1091
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 4
ER -